Collaborative Seed Grants
GIDI supports a seed funding program for cross-Grounds collaborative research projects. The purpose of this program is to bring diverse investigators together to tackle important questions and perform transformative, interdisciplinary work that will differentiate the UVA research enterprise. Proposals involve investigative teams from a variety of disciplines, from different Schools across Grounds. Evidence of prior collaboration is not required, and the creation of new partnerships is encouraged.
Awards for 2019-2020 have been made. A new Request for Proposals will be posted here when opened.
Seed Grant Awardees
The goal of the GIDI iGrant Program is to support innovative, impactful research conducted by individuals. Consistent with GIDI's mission, these projects will promote trans-disciplinary research and extend GIDI's national and international footprint in infectious disease research.
Increasing Access to Cervical Cancer Prevention through Innovative Technology in Rural Nicaragua: Culturally Tailored mHealth Approaches to Increase Impact
- Emma McKim Mitchell, PhD, MSN, RN
- Rebecca Dillingham, MD, MPH
Caused by high risk strains of Human Papillomavirus (HPV), cervical cancer is almost entirely preventable, yet significant morbidity and mortality persist in LMICs. Based on a long-term collaboration centered on access to care and cultural considerations for women's health on the Caribbean Coast of Nicaragua, we propose a novel combination of expertise on HPV screening and treatment (Mitchell), and an app/communication intervention (Dillingham) in order to: expand HPV DNA testing as primary screening in a culturally appropriate way to the Caribbean Coast of Nicaragua; implement telecolposcopy for women needing follow-up to decrease time to results communication and lost-to-follow-up rates; develop an app/communication intervention to decrease lost-to-follow-up rates and improve patient navigation; and to analyze the National cervical cancer registry in partnership with Movicancer.
- Bryan Lewis, PhD, MPH, Biocomplexity Institute & Initiative, UVA
- David Leblang PhD, Batten, CLAS
- Srini Venkatramanan, Research Scientist, Biocomplexity Institute & Initiative, UVA
Human mobility drives both spread and impact of infectious diseases, this is especially acute during complex humanitarian emergencies that displace people from their homes. We seek to undertake the development of a novel simulation framework that will bring together both migration attractors as well as repellers while simulating the spread of disease. We propose two case studies that will use this framework to estimate spread of disease across national borders and evaluate potential policy options.
- Farzad Hassanzadeh (SEAS)
- Jason Papin (SOM)
- Peter Kasson (SOM)
- Daniel Engel (SOM)
- Rebecca Pompano (CLAS)
- Young Hahn (SOM)
- John Lukens (SOM)
- Nathan Swami (SEAS)
- Jason Papin (SOM)
- Steven Zeichner (SOM)
Translating Discovery to Therapy: Customization and Delivery of Multifunctional Chemokine-derived Peptides for Treating Wound Infections caused by Multidrug-resistant Bacterial Pathogens
- Molly Hughes (SOM)
- Shayn Pierce-Cotter (SOM)
- Donald Griffin (SEAS)
- Bob Nakamoto (SOM)
Personalized Medicine for Clostridium Difficile Infection with Real-time Diagnosis of Microbiome and Antibiotic Resistance Profiles
- Martin Wu (CLAS)
- Ann Hays (SOM)
- Cirle Warren (SOM)
- Sook Hoang (SOM)